Automated Cell Culture Systems Market: Overview
Automated cell culture systems have gained popularity for generating optimized cell lines across the entire spectrum ranging from seeding, feeding, passaging, to expansion of cells. They help meet strict standardization requirements, lowering contamination rates and minimizing human errors. Life sciences industries are harnessing automated systems for a wide spectrum of cell-based screening use in research and commercial applications. Demand in the automated cell culture systems market stems from the expanding the use of high-throughput cell lines in drug discovery research.
Automated cell culture helps in the production of large volumes and high-quality cell lines for drug research, rendering high safety and product efficacy. Other key research applications in the market are interference RNA (RNAi), cell-based drug transport, metabolism, and toxicology studies.
The report offers an in-depth insights into key growth dynamics, regulatory landscape, new avenues, and revenues in key applications. The assessments strive to take a closer look at the automation trends and key winning imperatives that may heavily influence the competitive dynamics in coming years.
Automated Cell Culture Systems Market: Key Trends
Human pluripotent stem cell studies hold vast potential in modelling human diseases. Strides in the automated cell culture systems market have made this possible, and offer significant advantages over the manual ones. The growing popularity of personalized regenerative or cell replacement therapies is a key trend. Rapidly growing number of stem cell–based studies in developing and developed countries has imparted a robust fillip to the expansion in the automated cell culture systems market. Over the years, with personalized regenerative medicine gathering traction among life science research companies, new avenues have emerged.
Advances being made in structural biology have also spurred growth of the automated cell culture systems market.
Automated Cell Culture Systems Market: Competitive Analysis and Key Developments
Adoption of human iPSC lines in the generation of human iPSC lines has opened a new avenue in the automated cell culture systems market. They are benefitting from the development, manufacturing and customization of precision measurement devices. The generation of biobanks of iPSCs is a key trend in the automated cell culture systems market in developed regions, and is a key factor spurring industry collaborations of various types.
A case in point is when The California Institute for Regenerative Medicine (CIRM) collaborating with Cellular Dynamics International, Inc. (CDI) in the U.S. planned to generate 9000 iPSC lines from 3000 individuals. A number of consortiums have cropped up to this end. An example is The European Bank for induced pluripotent Stem Cells (EBiSC). Induced pluripotent stem cells cater to a wide range of diseases. Another example is the AUTOSTEM Consortium using automated cell culture systems for developing patient-specific iPSCs for ophthalmic research. Expanding the cell line in this manner will boost clinical trials for various diseases. Patients with ischemic strokes are likely to benefit from the clinical trials in Phase II from the adoption of automated cell culture system in CTX0E03 cell line.
Key industry players thriving in the automated cell culture systems market are Lonza Group Ltd., Merck KGaA, Promocell GmbH, and Hamilton Medical AG.
Automated Cell Culture Systems Market: Regional Assessment
Regionally, North America has been presenting substantial revenue streams for manufacturers of automated cell culture systems. The healthcare system in developed parts of the region has seen personalized regenerative or cell replacement therapies gathering immense traction. Stakeholders in the region are leaning on the extensive application of automated stem cell culture in stem cell studies. The regional market has seen players constantly focusing on investing to expand the capacities of automated cell culture systems. The regional market has also benefitted from the increasing trend of modernization of stem cell biology.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.